Trump Secures Lower Drug Prices from France Through Ultimatum, Altering French Policy.

Successful Negotiations Between the U.S. and France

According to Novyny.live: Talks between the United States and European leaders concluded successfully, with France notably agreeing to alter its pricing policy for pharmaceuticals. On March 9, 2023, U.S. President Donald Trump held a press conference at the White House to announce the results of the negotiations.

France and other nations committed to changing their pricing policies, leading to a substantial reduction in drug costs. Specifically, the price of medications for Americans in France dropped from 130 dollars to 20 dollars.

“I have the executive order ready, it’s right here on my desk, and I’m going to sign it!” - Donald Trump

Simultaneously, Trump issued an ultimatum regarding the potential imposition of 100% tariffs on imports of French wine and champagne. In response, French President Emmanuel Macron expressed his agreement:

“Donald, I agree to this.” - Emmanuel Macron

Consequently, the negotiations between the U.S. and France have opened a new chapter in the cooperation between the two countries in the spheres of healthcare and trade.

Impact of the New Policy on Drug Accessibility

These changes in pricing policy could significantly impact medication accessibility for Americans, which may in turn reduce the financial burden on the U.S. healthcare system. This high-stakes negotiation highlights the complex intersection of trade and public health policy. Cooperation between nations in this area signals a new phase in international relations, where economic and medical interests are intertwined, potentially paving the way for further agreements in the future.